Its role Owner
Laboratorios Kener, S.A. de C.V. is a Mexican pharmaceutical company founded in 1960 that specializes in the development, manufacture, marketing, and distribution of high-quality sterile medications, with a primary focus on injectables for hospital use.
The company operates a modern production facility in the Toluca 2000 industrial park in the State of Mexico, where it produces products in therapeutic areas including analgesia, anesthesia, anti-infectives, cardiology, ophthalmology, gastroenterology, and oncology support. It supplies both public healthcare institutions and private hospitals across Mexico, emphasizing compliance with national and international quality standards.
In 2024, Laboratorios Kener was acquired by Grupo Empresarial Ángeles (GEA) for approximately US$200 million and integrated into Grupo Vazol, strengthening its position within a larger healthcare group that includes hospital operations. The company has undertaken significant expansions, including ongoing investments exceeding MXN 10 billion for increased injectable capacity, a compounding center, biotechnology facilities, and a plasma-derived products plant, aimed at enhancing national pharmaceutical sovereignty and creating thousands of jobs.
As a leader in Mexico's hospital sterile pharmaceuticals segment, Kener maintains a portfolio of over 140 specialized products and continues to expand its capabilities in advanced manufacturing and export markets.
Also known as Kener Laboratorio.
chemXplore tracks 1 project involving Kener, of which one is active.
active all projects
